An experimental six-strain Lyme vaccine has demonstrated more than 70% efficacy in preventing Lyme disease in people aged ...

Vital safety checks were not carried out on Covid vaccines before they were rolled out to millions, Germany’s pandemic ...

Total revenues of €174.7 million in line with guidance, including €157.9 million in product sales Strong year-end cash position of €109.7 ...

A top U.S. health official said Thursday he was encouraged by interviews to select the next permanent leader of the Centers ...

Sachs Media is widening its reach in the health policy space with the debut of SachsHEALTH, a new division aimed at helping ...

There are currently no Lyme disease vaccines approved for people; a previous vaccine from 1998 was pulled from the market after reports of adverse events and poor sales, The Washington Post reported.

Pfizer said its experimental Lyme disease vaccine was more than 70% efficacious in reducing confirmed cases of the tickborne ...

The drugmaker is seeking regulatory review for the first new shot to combat the disease in decades.

There hasn't been an approved Lyme disease vaccine for more than 20 years, after GSK pulled its shot due to a lack of demand.

Pfizer wants to fill a 20-year void in human Lyme disease vaccines, but must win over regulators under a vaccine-skeptical ...

Presented by Alliance for Aging Research{beacon} Health Care Health Care PRESENTED BY The Big Story Pfizer’s Lyme disease ...

If approved by regulators, it could become the only Lyme disease vaccine available for people — although it would not be the ...